Fig. 1: Erastin-induced ferroptosis in bone marrow-derived stem cells (BMSCs).
From: The NSUN5-FTH1/FTL pathway mediates ferroptosis in bone marrow-derived mesenchymal stem cells
A–C The fraction of dead cells (A, B) and total iron levels (C) were greater in BMSCs treated with erastin than in the control group. **p < 0.05. D–G ROS (D) and lipid peroxide (E–G) levels were higher in erastin-treated cells than in control cells. **p < 0.05 (B–G).
